Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Talaris Therapeutics Inc (TALS)

Talaris Therapeutics Inc (TALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 116,318
  • Shares Outstanding, K 42,764
  • Annual Sales, $ 0 K
  • Annual Income, $ -73,890 K
  • EBIT $ -80 M
  • EBITDA $ -80 M
  • 60-Month Beta 2.18
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.78
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.64
  • Most Recent Earnings $-0.20 on 08/14/23
  • Next Earnings Date 11/09/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +217,273.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.53 +7.51%
on 10/10/23
3.13 -13.10%
on 10/16/23
-0.20 (-6.85%)
since 09/19/23
3-Month
2.53 +7.51%
on 10/10/23
3.13 -13.10%
on 10/16/23
-0.29 (-9.63%)
since 07/19/23
52-Week
0.89 +205.62%
on 12/28/22
3.29 -17.33%
on 07/10/23
+0.30 (+12.40%)
since 10/19/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APRN, RENB, TALS, WMC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

APRN : 12.99 (-0.08%)
RENB : 1.6400 (+6.15%)
TALS : 27.20 (-0.73%)
WMC : 9.18 (+4.44%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, TALS, QUOT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DEN : 88.66 (-0.26%)
TALS : 27.20 (-0.73%)
QUOT : 3.99 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, DEN, TALS, QUOT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AEL : 56.47 (+0.55%)
DEN : 88.66 (-0.26%)
TALS : 27.20 (-0.73%)
QUOT : 3.99 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEX, TALS, QUOT, SURF

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEX : 10.61 (+0.95%)
TALS : 27.20 (-0.73%)
QUOT : 3.99 (unch)
SURF : 1.0700 (-0.93%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, TALS, QUOT, CFMS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NETI : 11.33 (+0.09%)
TALS : 27.20 (-0.73%)
QUOT : 3.99 (unch)
CFMS : 2.26 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, NETI, TALS, QUOT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
NETI : 11.33 (+0.09%)
TALS : 27.20 (-0.73%)
QUOT : 3.99 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, QUOT, TALS, CFMS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NETI : 11.33 (+0.09%)
QUOT : 3.99 (unch)
TALS : 27.20 (-0.73%)
CFMS : 2.26 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, QUOT, TALS, CFMS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DICE : 47.55 (+0.06%)
QUOT : 3.99 (unch)
TALS : 27.20 (-0.73%)
CFMS : 2.26 (unch)
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, DICE, NEX, NETI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TALS : 27.20 (-0.73%)
DICE : 47.55 (+0.06%)
NEX : 10.61 (+0.95%)
NETI : 11.33 (+0.09%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, SURF, NEX, CIR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TALS : 27.20 (-0.73%)
SURF : 1.0700 (-0.93%)
NEX : 10.61 (+0.95%)
CIR : 56.00 (+5.16%)

Business Summary

Talaris Therapeutics Inc. is a late-clinical stage cell therapy company. It involved in developing a method of allogeneic hematopoietic stem cell transplantation with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases and certain severe...

See More

Key Turning Points

3rd Resistance Point 2.88
2nd Resistance Point 2.84
1st Resistance Point 2.78
Last Price 27.20
1st Support Level 2.67
2nd Support Level 2.63
3rd Support Level 2.57

See More

Last Price 27.20
52-Week High 3.29
Fibonacci 61.8% 2.37
Fibonacci 50% 2.09
Fibonacci 38.2% 1.81
52-Week Low 0.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar